Treatment options for patients with recurrent Graves hyperthyroidism after anti-thyroid drug treatment / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
;
(12): 903-906, 2019.
Artículo
en Chino
| WPRIM
| ID: wpr-791735
ABSTRACT
Graves'disease (GD) is the most common cause of hyperthyroidism, and its treatment includes anti-thyroid drugs (ATD), radioactive iodine therapy (RAI), and surgical treatment. ATD is the first choice for GD treatment in China, but the high recurrence rate limits its widely clinical application. The therapeutic strategy for patients with recurrent hyperthyroidism after ATD treatment is still controversial.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Endocrinology and Metabolism
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS